Anti-TLR3 / CD283 (CNTO5429), 1mg*25

Anti-TLR3 / CD283 (CNTO5429), 1mg*25

Enavatuzumab (Anti-TNFRSF12A / TWEAKR / CD266), 1mg*5

Enavatuzumab (Anti-TNFRSF12A / TWEAKR / CD266), 1mg*5

Enavatuzumab (Anti-TNFRSF12A / TWEAKR / CD266), 1mg

2.614,43 RON
SKU
SKM_A2697_1mg

Enavatuzumab (Anti-TNFRSF12A / TWEAKR / CD266) is a humanized monoclonal antibody directed against the tumor necrosis factor-like weak inducer of apoptosis receptor (TWEAKR) with potential antineoplastic, immunomodulating and antiangiogenic activities. MW : 150 kD.

Mai multe informatii
Price 2.197,00 RON (preturile sunt fara TVA)
Description

Enavatuzumab (Anti-TNFRSF12A / TWEAKR / CD266) is a humanized monoclonal antibody directed against the tumor necrosis factor-like weak inducer of apoptosis receptor (TWEAKR) with potential antineoplastic, immunomodulating and antiangiogenic activities. MW : 150 kD.